Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C16H15Cl2N5O2S |
| Molecular Weight | 412.294 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O[C@@H]1CS[C@H]([C@@H]1O)N2C=NC3=C2N=C(Cl)N=C3NCC4=CC=CC(Cl)=C4
InChI
InChIKey=JQUBXCDDRXAMLF-IXPVHAAZSA-N
InChI=1S/C16H15Cl2N5O2S/c17-9-3-1-2-8(4-9)5-19-13-11-14(22-16(18)21-13)23(7-20-11)15-12(25)10(24)6-26-15/h1-4,7,10,12,15,24-25H,5-6H2,(H,19,21,22)/t10-,12-,15-/m1/s1
| Molecular Formula | C16H15Cl2N5O2S |
| Molecular Weight | 412.294 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 10:42:08 GMT 2025
by
admin
on
Wed Apr 02 10:42:08 GMT 2025
|
| Record UNII |
L4A6E7Q76T
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
796620
Created by
admin on Wed Apr 02 10:42:08 GMT 2025 , Edited by admin on Wed Apr 02 10:42:08 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
L4A6E7Q76T
Created by
admin on Wed Apr 02 10:42:08 GMT 2025 , Edited by admin on Wed Apr 02 10:42:08 GMT 2025
|
PRIMARY | |||
|
300000020871
Created by
admin on Wed Apr 02 10:42:08 GMT 2025 , Edited by admin on Wed Apr 02 10:42:08 GMT 2025
|
PRIMARY | |||
|
16735504
Created by
admin on Wed Apr 02 10:42:08 GMT 2025 , Edited by admin on Wed Apr 02 10:42:08 GMT 2025
|
PRIMARY | |||
|
945457-84-1
Created by
admin on Wed Apr 02 10:42:08 GMT 2025 , Edited by admin on Wed Apr 02 10:42:08 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|